Use UNICORN Signals App By EquityPandit
MARKETS

Stocks in Focus: Power Mech Projects, Cochin Shipyard, Religare Enterprises, and Others

Picture Source: Internet

The GIFT Nifty futures, which is an early indicator of the Nifty50 index, was trading 0.10% higher by 24.5 points at 24,370, indicating that the domestic benchmark indices are likely to make a lacklustre start on Monday. 

On Friday, 29 November, Domestic benchmark indices S&P BSE Sensex surged 759 points or 0.96% to end at 79,803 while the Nifty50 traded 217 points higher or 0.91% and settled at 24,131.

Here are some stocks that are likely to remain in focus on 2 December.

Power Mech Projects: The company announced securing an order worth Rs 510 crore from Adani Power. The scope of the order is related to the performance of Mechanical construction works for the 2×800 MW Raipur Phase-II Ultra Supercritical Thermal Power Project (Project) at Raikheda village in Raipur District, Chhattisgarh.

Cochin Shipyard: The company has signed a contract with the Ministry of Defence for Short Refit and Dry Docking (SRDD) of INS Vikramaditya for a total cost of Rs 1,207.5 crore. 

Religare Enterprises: The company has received warning letters from stock exchanges for delaying the disclosure of the Reserve Bank of India’s refusal for the appointment of Rakesh Asthana as additional director. 

ONGC: The company’s overseas investment subsidiary, ONGC Videsh, has completed acquiring Norwegian firm Equinor’s stake in an oilfield and an associated pipeline in Azerbaijan for a total consideration of $60 million.

KEC International: The company has announced securing orders worth Rs 1,040 crore through its Transmission and Distribution (T&D) business in international markets, which is for supplying towers, hardware, and poles for projects in America. 

DLF: The joint venture of the company DCCDL has an IT park in Kolkata to Primarc and RDB group for a total consideration of Rs 637 crore. 

Biocon: The company’s subsidiary, Biocon Biologics Ltd, has announced that the US Food and Drug Administration (USFDA) has provided approval for YESINTEK (Ustekinumab-kfce), which is a biosimilar to reference listed drug Stelara (Ustekinumab). 

Ashok Leyland: The company’s financial services subsidiary, Hinduja Leyland Finance, has announced its plans to raise $300-500 million through the debut issuance of dollar bonds during this fiscal year.

The future of investing is here!
Unicorn Signals leverages advanced AI technology to provide you with powerful market predictions and actionable stock scans. Download the app todayand 10x your trading & investing journey!

Get Daily Prediction & Stocks Tips On Your Mobile


Latest
IPO
Weekly
Outlook

Stock
Market
Prediction